Tissue-like, nonlinearly elastic nanobiomaterials for soft tissue regeneration. The purpose of this project is to advance the discipline of soft tissue engineering and regeneration with novel biomaterials, nanotechnology and novel clinical treatment concepts. The key outcomes include new elastic tissue-like nanobiomaterials, new varieties of medical implants and innovative treatment methodology.
Structural design of third generation biomaterials. This project will design third generation biomaterials for heart valves, cartilage and bones that guide the formation of new tissue whilst being dissolved inside the human body. As a result, it is anticipated that painful and costly revision surgery will become obsolete. Major benefits will be achieved in paediatric health as implants will have the ability to grow with the child.
Biomaterials with multifaceted tunability and bio-specificity. Polyurethanes, a family of polymers with independently tunable mechanical and biodegradation properties, will be developed as a versatile platform material for biomedical implants. Novel energetic ion treatments that allow the coupling of bioactive agents to surfaces will eliminate adverse reactions and enable integration with surrounding tissue.
Biochemistry of tropoelastin and elastin. Elastin is the main protein responsible for the elasticity of vertebrate tissues. The Weiss Lab makes large quantities of full-length tropoelastin, which is crosslinked to make elastin. We want to examine the biochemistry of tropoelastin, learn how its domains participate in elastin structure and assembly, and explore cellular responses to our synthetic elastin biomaterial. Remarkably little is known of this biochemistry because elastin is a highly cross ....Biochemistry of tropoelastin and elastin. Elastin is the main protein responsible for the elasticity of vertebrate tissues. The Weiss Lab makes large quantities of full-length tropoelastin, which is crosslinked to make elastin. We want to examine the biochemistry of tropoelastin, learn how its domains participate in elastin structure and assembly, and explore cellular responses to our synthetic elastin biomaterial. Remarkably little is known of this biochemistry because elastin is a highly cross-linked and substantially insoluble macroscopic network of tropoelastin multimers. Our availability of tropoelastin and synthetic elastin now makes these studies possible.Read moreRead less
New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required ....New Materials for an Implantable Blood Pump. Rotary blood pumps are at the leading edge of heart assist technology. VentrAssist has developed an innovative rotary blood pump with a hydro-dynamically suspended impeller. Advanced surface modifications will enable the device to be fabricated from polymers; this will make the device light, more compatible with the human body and less costly to produce. Surface treatments and coatings will be applied using ion implantation, to impart the required dimensional stability, impermeability and wear resistance. Following sophisticated experiments of modified materials, the best candidates will be used in prototype devices, for final selection of the optimal materials for the new device.Read moreRead less
Bioengineering Endovascular Prostheses With Proactive Biocompatibility
Funder
National Health and Medical Research Council
Funding Amount
$627,950.00
Summary
Metallic cardiovascular implants, such as stents, used in the treatment of heart disease are not compatible with blood. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of metal alloys, and shown a significant improvement in their compatibility. Stents coated using our technology stand to dramatically improve the treatment of cardiovascular disease.
Development Of Endovascular Stents With Proactive Biocompatibility
Funder
National Health and Medical Research Council
Funding Amount
$428,470.00
Summary
Metallic cardiovascular implants, such as stents, used in the treatment of heart disease are not compatible with blood. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of metal alloys, and shown a significant improvement in their compatibility. Stents coated using our technology stand to dramatically improve the treatment of cardiovascular disease.
Bioengineering Synthetic Elastin Conduits For Arterial Revascularisation
Funder
National Health and Medical Research Council
Funding Amount
$624,776.00
Summary
An arterial substitute with both physical and biological properties that mimic those of the human vasculature has long been the holy grail of vascular tissue engineering. We propose synthetic elastin can form the basis of a durable, clinically effective small diameter vascular graft and fill a significant unmet need for a biocompatible vascular substitute.
Biocompatible Synthetic Conduits To Treat Vascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$421,818.00
Summary
Clinically available synthetic conduits used in vascular repair and bypass are fundamentally incompatible with the vasculature. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of all polymeric materials and have shown a significant improvement in their compatibility. Grafts coated using our technology stand to dramatically improve the treatment of vascular diseas ....Clinically available synthetic conduits used in vascular repair and bypass are fundamentally incompatible with the vasculature. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of all polymeric materials and have shown a significant improvement in their compatibility. Grafts coated using our technology stand to dramatically improve the treatment of vascular disease.Read moreRead less
Broad spectrum nanomedicine for Meningitis treatment. Brain inflammatory diseases are among the top ten infectious causes of death. The project aims to provide Australian doctors with a superior alternative of treating infections that do not respond to conventional antibiotics. The nanomedicine developed will reduce the burden of hospital and boost Australia economy in the biomedical sector.